018680 — Seoul Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Seoul Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13,820	11,728	9,664	7,540	9,949
Net Total Accounts Receivable
Net Total Receivables	4,489	5,040	5,131	9,465	12,546
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24,814	26,012	25,609	32,257	34,014
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,055	30,676	31,330	33,855	32,124
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	62,250	62,428	63,305	71,620	71,754
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28,805	13,891	20,532	14,141	14,898
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	43,292	27,006	24,741	31,448	30,705
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	18,958	35,422	38,564	40,172	41,050
Total Liabilities & Shareholders' Equity	62,250	62,428	63,305	71,620	71,754
Total Common Shares Outstanding